Corvus Pharmaceuticals Inc

NEW
STU:C17 (USA)  
€ 12.81 -0.21 (-1.65%) Aug 14
At Loss
P/B:
5.56
Market Cap:
€ 1.09B ($ 1.26B)
Enterprise V:
€ 900.02M ($ 1.04B)
Volume:
500.00
Avg Vol (2M):
1.85K
Trade In:

Corvus Pharmaceuticals Inc (STU:C17) Dividend

Corvus Pharmaceuticals Inc (STU:C17) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -17.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:C17 Dividend

Does Corvus Pharmaceuticals Inc (STU:C17) pay a dividend?

Corvus Pharmaceuticals Inc (STU:C17) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Corvus Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Corvus Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -17.1% over the past 3 years.

What are dividend-paying alternatives to Corvus Pharmaceuticals Inc?

For dividend-paying alternatives in Corvus Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.